Sustained weight loss with semaglutide 2.4 mg for management of obesity in STEP 4 & 5 trials
11 Jun 2025
Semaglutide 2.4 mg supports transformative weight loss when used in the long term, with ≥20% weight loss in 1 in 3 patients.
This was the key finding from the STEP 5 trial of adults with overweight or obesity treated with semaglutide 2.4 mg vs placebo.
Resources
Sustained weight loss with semaglutide 2.4 mg for management of obesity in STEP 4 & 5 trials
Sustained weight loss with semaglutide 2.4 mg for management of obesity in STEP 4 & 5 trials